| Application number | Title of the application | Filing Date | Status |
|---|
| 09/049502 | DENDRITIC-LIKE CELL/TUMOR CELL HYBRIDS AND HYBRIDOMAS FOR INDUCING AN ANTI-TUMOR RESPONSE | Mar 26, 1998 | Abandoned |
Array
(
[id] => 7619944
[patent_doc_number] => 06943239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-13
[patent_title] => 'Antigenic fusionprotein carrying Galα1,3Gal epitopes'
[patent_app_type] => utility
[patent_app_number] => 09/194396
[patent_app_country] => US
[patent_app_date] => 1998-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9964
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/943/06943239.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194396
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194396 | Antigenic fusionprotein carrying Galα1,3Gal epitopes | Mar 25, 1998 | Issued |
Array
(
[id] => 1560969
[patent_doc_number] => 06362001
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => 'Method for producing a synthetic antigen presenting transformed Drosophila cell'
[patent_app_type] => B1
[patent_app_number] => 09/042492
[patent_app_country] => US
[patent_app_date] => 1998-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 30654
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/362/06362001.pdf
[firstpage_image] =>[orig_patent_app_number] => 09042492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/042492 | Method for producing a synthetic antigen presenting transformed Drosophila cell | Mar 15, 1998 | Issued |
| 09/030985 | INDUCTION OF TUMOR AND VIRAL IMMUNITY USING ANTIGEN PRESENTING CELL CO-CULTURE PRODUCTS AND FUSION PRODUCTS | Feb 25, 1998 | Abandoned |
| 09/016361 | PEPTIDES AND PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL | Jan 29, 1998 | Abandoned |
Array
(
[id] => 1148722
[patent_doc_number] => 06770460
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-03
[patent_title] => 'Fusion protein and its use in an immunoassay for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus'
[patent_app_type] => B1
[patent_app_number] => 09/015399
[patent_app_country] => US
[patent_app_date] => 1998-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 8175
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770460.pdf
[firstpage_image] =>[orig_patent_app_number] => 09015399
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/015399 | Fusion protein and its use in an immunoassay for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus | Jan 28, 1998 | Issued |
| 09/012330 | METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS | Jan 22, 1998 | Abandoned |
Array
(
[id] => 4134940
[patent_doc_number] => 06147203
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Recombinant disulfide-stabilized polypeptide fragments having binding specificity'
[patent_app_type] => 1
[patent_app_number] => 9/002753
[patent_app_country] => US
[patent_app_date] => 1998-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18057
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/147/06147203.pdf
[firstpage_image] =>[orig_patent_app_number] => 002753
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/002753 | Recombinant disulfide-stabilized polypeptide fragments having binding specificity | Jan 4, 1998 | Issued |
| 08/981340 | NOVEL PEPTIDES FOR USE IN TREATMENT OF T-CELL MEDIATED CARTILAGE DESTRUCTION IN AUTOIMMUNE DISEASES | Dec 17, 1997 | Abandoned |
Array
(
[id] => 1309785
[patent_doc_number] => 06613536
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus'
[patent_app_type] => B1
[patent_app_number] => 08/913994
[patent_app_country] => US
[patent_app_date] => 1997-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 23
[patent_no_of_words] => 12243
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613536.pdf
[firstpage_image] =>[orig_patent_app_number] => 08913994
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/913994 | Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus | Sep 28, 1997 | Issued |
Array
(
[id] => 1350658
[patent_doc_number] => 06576239
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-10
[patent_title] => 'Angiogenic homing molecules and conjugates derived therefrom'
[patent_app_type] => B1
[patent_app_number] => 08/926914
[patent_app_country] => US
[patent_app_date] => 1997-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 28
[patent_no_of_words] => 29088
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576239.pdf
[firstpage_image] =>[orig_patent_app_number] => 08926914
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/926914 | Angiogenic homing molecules and conjugates derived therefrom | Sep 9, 1997 | Issued |
Array
(
[id] => 1453351
[patent_doc_number] => 06461867
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Synthetic antigen presenting matrix'
[patent_app_type] => B1
[patent_app_number] => 08/913612
[patent_app_country] => US
[patent_app_date] => 1997-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 48
[patent_no_of_words] => 36824
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461867.pdf
[firstpage_image] =>[orig_patent_app_number] => 08913612
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/913612 | Synthetic antigen presenting matrix | Sep 7, 1997 | Issued |
Array
(
[id] => 1451318
[patent_doc_number] => 06455678
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Human hematopoietic stem and progenitor cell antigen'
[patent_app_type] => B1
[patent_app_number] => 08/842382
[patent_app_country] => US
[patent_app_date] => 1997-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 17630
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455678.pdf
[firstpage_image] =>[orig_patent_app_number] => 08842382
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/842382 | Human hematopoietic stem and progenitor cell antigen | Apr 22, 1997 | Issued |
Array
(
[id] => 975162
[patent_doc_number] => 06932970
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-23
[patent_title] => 'Peptides for the treatment and diagnosis of systemic lupus erythematosus'
[patent_app_type] => utility
[patent_app_number] => 08/833838
[patent_app_country] => US
[patent_app_date] => 1997-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7866
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/932/06932970.pdf
[firstpage_image] =>[orig_patent_app_number] => 08833838
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/833838 | Peptides for the treatment and diagnosis of systemic lupus erythematosus | Apr 9, 1997 | Issued |
Array
(
[id] => 5843455
[patent_doc_number] => 20020131963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING TYPE I DIABETES USING GLUTAMIC ACID DECARBOXYLASE'
[patent_app_type] => new
[patent_app_number] => 08/838486
[patent_app_country] => US
[patent_app_date] => 1997-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11757
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20020131963.pdf
[firstpage_image] =>[orig_patent_app_number] => 08838486
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/838486 | METHODS AND COMPOSITIONS FOR TREATING TYPE I DIABETES USING GLUTAMIC ACID DECARBOXYLASE | Apr 6, 1997 | Abandoned |
Array
(
[id] => 6274726
[patent_doc_number] => 20020106370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'IMPROVEMENTS IN OR RELATING TO PEPTIDE DELIVERY'
[patent_app_type] => new
[patent_app_number] => 08/737457
[patent_app_country] => US
[patent_app_date] => 1997-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5748
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106370.pdf
[firstpage_image] =>[orig_patent_app_number] => 08737457
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/737457 | IMPROVEMENTS IN OR RELATING TO PEPTIDE DELIVERY | Mar 11, 1997 | Abandoned |
Array
(
[id] => 6876636
[patent_doc_number] => 20010006789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'METHOD FOR DETECTING T CELL RESPONSE TO SPECIFIC ANTIGENS IN WHOLE BLOOD'
[patent_app_type] => new-utility
[patent_app_number] => 08/803702
[patent_app_country] => US
[patent_app_date] => 1997-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4577
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20010006789.pdf
[firstpage_image] =>[orig_patent_app_number] => 08803702
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/803702 | Method for detecting T cell response to specific antigens in whole blood | Feb 20, 1997 | Issued |
| 08/804106 | ULCERATIVE COLITIS PANCA SECRETORY VESICLE ANTIGEN AND METHODS OF USING SAME | Feb 19, 1997 | Abandoned |
Array
(
[id] => 5843464
[patent_doc_number] => 20020131966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'ANTI-IDIOTYPIC ANTIBODIES OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND USE THEREOF AS DRUGS'
[patent_app_type] => new
[patent_app_number] => 09/091561
[patent_app_country] => US
[patent_app_date] => 1998-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8258
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20020131966.pdf
[firstpage_image] =>[orig_patent_app_number] => 09091561
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/091561 | Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs | Dec 19, 1996 | Issued |
| 08/716169 | PEPTIDE FRAGMENTS OF MICROBIAL STRESS PROTEINS AND PHARMACEUTICAL COMPOSITION MADE THEREOF FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES | Dec 16, 1996 | Abandoned |